Rapid Micro Biosystems announces the 2013 availability of Growth Direct™ Systems
New applications improve the efficiency of microbial quality control processes...
List view / Grid view
New applications improve the efficiency of microbial quality control processes...
16 April 2012 | By Merck
Vintafolide is currently being evaluated in a Phase III clinical trial...
13 April 2012 | By HORIBA Scientific
Bio-Rad’s KnowItAll® Informatics System software offered for use with the HORIBA Scientific range of Raman spectrometers...
13 April 2012 | By HORIBA Scientific
HORIBA Scientific, is proud to announce the organization of a label-free conference, in cooperation with ELSEVIER...
12 April 2012 | By Catalent Pharma Solutions
Dr. Browne & Mr. Meissonnier will present...
Lonza and Agennix AG announced today an agreement for the production of Agennix’s first-in-class oral Dendritic Cell Mediated Immunotherapy (DCMI), talactoferrin, currently in Phase III testing for the treatment of non-small cell lung cancer (NSCLC).
12 April 2012 | By BASF
After acquiring Cognis in 2011, BASF has significantly expanded its range of solubilization and dermatology excipients...
11 April 2012 | By GlaxoSmithKline
GlaxoSmithKline has published its Corporate Responsibility Report...
11 April 2012 | By Catalent Pharma Solutions
Dr. Lei Mao, Project Director and Group Leader, R&D of Catalent Pharma Solutions to present...
11 April 2012 | By
The European Commission has approved HUMIRA®...
Corning Incorporated (NYSE: GLW) announced today that it has reached a definitive agreement with BD (Becton, Dickinson and Company) (NYSE:BDX) to acquire the majority of its Discovery Labware unit for approximately $730 million in cash. The acquisition is expected to be completed later this year, subject to customary closing conditions,…
10 April 2012 | By Catalent Pharma Solutions
Esther Sadler-Williams will lead two discussions...
10 April 2012 | By Amgen
Amgen and KAI Pharmaceuticals have announced an agreement under which Amgen will acquire KAI...
9 April 2012 | By Abbott
Abbott announced it has received approval from the Japanese MHLW...
6 April 2012 | By Roche
Roche released the following statement in response to a report issued by Institutional Shareholder Services...